Skip to content
Recall Observatory FDA recall evidence

Drug product

Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30

D-0026-2019

September 10, 2018

Class II

Product summary

Firm
Takeda Development Center Americas, Inc.
Event
Event 80964
Status
Terminated
Classification
Class II
Quantity
7,248 bottles
Official record key
drug-enforcement:D-0026-2019

Official wording

Reason: Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Code information: Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020

Distribution pattern: AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.